WallStreetZenWallStreetZen

NASDAQ: BIVI
Biovie Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for BIVI

Based on 3 analysts offering 12 month price targets for Biovie Inc.
Min Forecast
$7.00+50.54%
Avg Forecast
$8.00+72.04%
Max Forecast
$9.00+93.55%

Should I buy or sell BIVI stock?

Based on 3 analysts offering ratings for Biovie Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BIVI stock forecasts and price targets.

BIVI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
EF Hutton
Bottom 1%
1
Strong BuyMaintains$8.00+72.04%2022-09-28
Cantor Fitzgerald
Top 2%
99
Strong BuyInitiates Coverage On$7.00+50.54%2022-07-22
Oppenheimer
Top 10%
91
BuyInitiates Coverage On$9.00+93.55%2022-03-15

1 of 1

Forecast return on equity

Is BIVI forecast to generate an efficient return?
Company
-1,208.83%
Industry
15.35%
Market
62.84%
BIVI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BIVI forecast to generate an efficient return on assets?
Company
-315.23%
Industry
13.55%
BIVI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BIVI earnings per share forecast

What is BIVI's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.21
Avg 2 year Forecast
-$2.09
Avg 3 year Forecast
-$2.36

BIVI revenue forecast

What is BIVI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$30.9M
Avg 2 year Forecast
$131.1M
Avg 3 year Forecast
$29.4M

BIVI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BIVI$4.65$8.00+72.04%Strong Buy
VXRT$1.08$7.00+548.15%Buy
TCRT$0.67$3.00+350.45%Strong Buy
RVLP$1.46$3.50+139.73%Buy
CABA$5.00$8.00+60.00%Strong Buy
View Top Biotech Stocks

Biovie Stock Forecast FAQ

Is Biovie Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: BIVI) stock is to Strong Buy BIVI stock.

Out of 3 analysts, 2 (66.67%) are recommending BIVI as a Strong Buy, 1 (33.33%) are recommending BIVI as a Buy, 0 (0%) are recommending BIVI as a Hold, 0 (0%) are recommending BIVI as a Sell, and 0 (0%) are recommending BIVI as a Strong Sell.

If you're new to stock investing, here's how to buy Biovie stock.

What is BIVI's earnings growth forecast for 2023-2025?

(NASDAQ: BIVI) Biovie's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Biovie's earnings in 2022 is -$30,959,429.On average, 2 Wall Street analysts forecast BIVI's earnings for 2023 to be -$36,944,724, with the lowest BIVI earnings forecast at -$50,684,498, and the highest BIVI earnings forecast at -$22,899,623. On average, 1 Wall Street analyst forecast BIVI's earnings for 2024 to be -$63,813,615, with the lowest BIVI earnings forecast at -$63,813,615, and the highest BIVI earnings forecast at -$63,813,615.

In 2025, BIVI is forecast to generate -$72,057,479 in earnings, with the lowest earnings forecast at -$72,057,479 and the highest earnings forecast at -$72,057,479.

What is BIVI's revenue growth forecast for 2024-2026?

(NASDAQ: BIVI) Biovie's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Biovie's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast BIVI's revenue for 2024 to be $943,464,447, with the lowest BIVI revenue forecast at $943,464,447, and the highest BIVI revenue forecast at $943,464,447. On average, 1 Wall Street analysts forecast BIVI's revenue for 2025 to be $4,002,854,013, with the lowest BIVI revenue forecast at $4,002,854,013, and the highest BIVI revenue forecast at $4,002,854,013.

In 2026, BIVI is forecast to generate $896,962,947 in revenue, with the lowest revenue forecast at $813,822,051 and the highest revenue forecast at $980,103,843.

What is BIVI's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: BIVI) forecast ROA is -315.23%, which is lower than the forecast US Biotechnology industry average of 13.55%.

What is BIVI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year BIVI price target, the average BIVI price target is $8.00, with the highest BIVI stock price forecast at $9.00 and the lowest BIVI stock price forecast at $7.00.

On average, Wall Street analysts predict that Biovie's share price could reach $8.00 by Sep 28, 2023. The average Biovie stock price prediction forecasts a potential upside of 72.04% from the current BIVI share price of $4.65.

What is BIVI's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: BIVI) Biovie's current Earnings Per Share (EPS) is -$1.21. On average, analysts forecast that BIVI's EPS will be -$1.21 for 2023, with the lowest EPS forecast at -$1.66, and the highest EPS forecast at -$0.75. On average, analysts forecast that BIVI's EPS will be -$2.09 for 2024, with the lowest EPS forecast at -$2.09, and the highest EPS forecast at -$2.09. In 2025, BIVI's EPS is forecast to hit -$2.36 (min: -$2.36, max: -$2.36).

What is BIVI's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: BIVI) forecast ROE is -1,208.83%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.